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Abstract
 In 2017, 15.6% of the people living in England were born abroad,Background:
yet we have a limited understanding of their use of health services and
subsequent health conditions. This linked population-based cohort study aims
to describe the hospital-based healthcare and mortality outcomes of 1.5 million
non-European Union (EU) migrants and refugees in England.
We will link four data sources: first, non-EU migrantMethods and analysis: 
tuberculosis pre-entry screening data; second, refugee pre-entry health
assessment data; third, national hospital episode statistics; and fourth, Office of
National Statistics death records. Using this linked dataset, we will then
generate a population-based cohort to examine hospital-based events and
mortality outcomes in England between Jan 1, 2006, and Dec 31, 2017. We will
compare outcomes across three groups in our analyses: 1) non-EU
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  (0)Commentscompare outcomes across three groups in our analyses: 1) non-EU
international migrants, 2) refugees, and 3) general population of England.
We will obtain approval to use unconsentedEthics and dissemination: 
patient identifiable data from the Secretary of State for Health through the
Confidentiality Advisory Group and the National Health Service Research
Ethics Committee. After data linkage, we will destroy identifying data and
undertake all analyses using the pseudonymised dataset. The results will
provide policy makers and civil society with detailed information about the
health needs of non-EU international migrants and refugees in England.
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Introduction
In 2017, 8.6 million (15.6%) people living in England were 
born abroad, with 5.3 million (9.2%) born outside of the 
European Union (EU)1. However, little is known about how 
these international migrants use England’s National Health Service 
(NHS) or their subsequent health needs and mortality outcomes. 
Here we define international migrants as people born outside 
of England2. This may include, for example, people who either 
have chosen to migrate (e.g. work, study, or join families) or 
those who may have been forced to migrate due to conflict, 
persecution or environmental disasters (e.g. refugees and asylum 
seekers).
A previous systematic review of healthcare usage in Europe 
showed that usage of accident and emergency (A&E) services 
by international migrants was high, but that screening and 
outpatient care usage was low3. Similarly, a recent study from 
Scotland showed that some ethnic minorities, whether migrants 
or their offspring, have higher levels of avoidable hospital 
admissions when compared to the non-migrant white Scottish 
population4. These findings suggest that migrants may be 
receiving poor quality primary and preventative healthcare or 
face barriers to accessing health services.
In England, no large scale studies have been conducted to date 
that were able to examine migrants’ usage of hospital-based 
healthcare services. One primary care based study in England 
found that individuals who registered with a general practi-
tioner (GP) for the first time when over the age of 15 - used as a 
proxy for international migrants - had half the rate of hospital 
admissions than the general population5. However, another study 
found that only one-third of new migrants had registered with 
a GP, complicating the use of this proxy measure as well as 
highlighting poor uptake of primary healthcare registration6. 
Other studies in England7,8 have used country of birth to 
examine migration, but did not have information on the date of 
migration, the country which an individual was migrating from, 
or the visa category under which they entered England. These 
studies illustrate the methodological challenges of accurately 
identifying migrants within national data sources and the lack 
of available information on their migratory history, thus limiting 
the interpretations of previous research.
Despite poor access to preventative healthcare, there is 
evidence that migrants have a mortality advantage compared 
to host populations in the high-income countries to which they 
migrate. We recently conducted a systematic review and meta-
analysis on the global patterns of mortality data in international 
migrants9. Our review showed that the levels of mortality in 
international migrants, measured using standardised mortality 
ratios, were lower compared to the host population in the 
countries of destination for most disease causes. Two excep-
tions to these findings were an increase in mortality due to infec-
tious disease and external causes of mortality9. As we found 
very little data on refugees, asylum seekers and other forced 
migrants, our data is most representative of international 
migrants in high-income countries who are studying, working or 
have joined family members. Although our findings supported 
the idea of the healthy migrant hypothesis - an empirically 
observed mortality advantage of migrants relative to the host 
population10, there is evidence from migrants residing in 
England and Wales that suggests that this advantage declines 
with age7,8. However, these studies were not able to assess 
whether this advantage also changed with duration of residence in 
England.
The evaluation of morbidity and mortality outcomes of 
migrants has been limited by difficulties in their identification 
in national data sources. To date, we have no data in England 
linking migrant and refugee health service usage and subsequent 
health conditions and mortality outcomes. There are existing 
disparate data sources on the health of international migrants; 
however, despite their existence, these data have not been inte-
grated or analysed systematically. These data contain informa-
tion that would enable us to comprehensively evaluate the health 
needs in migrants and refugees and develop evidence on how 
to improve access to hospital-based health services and pre-
ventative healthcare in England. The Million Migrant study will 
generate this evidence for the first time by linking records that 
contain data on the health outcomes for 1.5 million non-EU 
migrants and refugees.
Aim and objectives
The Million Migrant study will be a population-based cohort 
study that aims to examine secondary healthcare performance 
(e.g. quality and accessibility) and mortality in 1.5 million non-
EU migrants and refugees in England. There are two main 
objectives of the study. First, to profile hospital-based health-
care performance by identifying existing health conditions and 
examining hospital admissions, readmissions and duration of 
admission of non-EU migrants and refugees compared to the 
general population in England. Second, to investigate mortal-
ity outcomes by health condition for non-EU migrants and refu-
gees in comparison to the general population. This objective 
will examine whether or not our data replicates the mortality 
advantage of international migrants found in the literature. The 
study includes analyses that acknowledge the wider determi-
nants influencing the health of international migrants such as 
the legal, social, economic and health structures and systems, 
health service access and support, exposures and behaviours, and 
epidemiological changes associated with population mobility 
(Figure 1).
Protocol
Data collection, processing, and linkage
Our study will link four data sources as outlined in Figure 2. 
First, non-EU migrant tuberculosis pre-entry screening data. 
This data set contain records on international non-EU migrants 
resident in a country where tuberculosis is common (40 cases 
per 100,000 people), and who are planning to come and live in 
United Kingdom (UK) for more than 6 months11. Individuals 
in this dataset were screened by the UK pre-entry tuberculosis 
screening programme between Jan 1, 2006, and Dec 31, 2017. 
UK pre-entry tuberculosis screening was conducted either 
by the International Organization for Migration (IOM) or by 
international clinics recognised by the UK Home Office and 
quality assessed by Public Health England (PHE). Second, refu-
gee pre-entry health assessment. Refugees undergo a health 
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Figure 1. Conceptual framework for influences on migration and health adapted from UCL-Lancet Commission on Migration and 
Health12. * The boxes and words in grey will not be measured directly in the Million Migrant study.
Figure 2. Study data flows.
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assessment that allows pre-departure information to be shared 
with local authorities and health services in the UK. Refugee 
health assessments were conducted by IOM between Mar 1, 
2013 and Dec 31, 2017. Our study will therefore include two 
cohorts of international migrants to the UK - non-EU migrants 
and refugees that will be linked to the final two datasets from 
Jan 1, 2006, and Dec 31, 2017. Third, national hospital episode 
statistics (HES), including hospital admissions and attend-
ances. Fourth, Office of National Statistics (ONS) death records 
which contain cause of death information on all deaths between 
Jan 1, 2006, and Dec 31, 2017. We focus on non-EU migrants 
because of their availability in this dataset, but also because EU 
migrants are more likely to dual-use health systems and less 
likely to need adaptation in terms of cultural competence13. The 
analysis will be limited to England as the HES data will only 
be obtainable for English hospitals.
We will obtain identifying variables (forename, surname, 
aliases, date of birth, sex, country of origin, country of depar-
ture, date of tuberculosis pre-entry screening or refugee pre-entry 
health assessment, and visa category) from all non-EU migrants 
and refugees under appropriate legal and ethical approvals. We 
will then use the Personal Demographics Service (PDS), the 
national electronic database of NHS patient information such 
as name, address, and date of birth, to identify and add NHS 
numbers by matching on these identifying variables to the 
tuberculous pre-entry screening and refugee health assessment 
records. Where available, NHS numbers that have already been 
added by PHE will be integrated. Once the non-EU migrants 
and refugees have been matched to their NHS number, we will 
then undertake deterministic linkage using NHS number to 
identify HES and ONS mortality records. Personal identifiers 
will then be removed, resulting in a pseudonymised linked 
dataset which will be securely transferred to UCL for data 
analysis, as outlined in Figure 2. We will compare match-
ing levels (e.g. whether an individual record is linked to their 
NHS number or not) across different age, sex, year and age 
of entry to UK and migrant country of origin groups. The 
non-EU migrant tuberculosis pre-entry screening data-
set might contain multiple duplicate records for some indi-
viduals who require repeat tuberculosis screening. Duplicate 
records will be analysed on the basis of whether they occurred 
within 12 months of each other or not as per previously defined 
rules14 provided in full in Extended data file 7. Non-EU migrant 
and refugee data are cleaned by the IOM epidemiology unit 
in coordination with clinics to ensure that records included all 
results on individuals screened and that any duplicate entries 
resulting from administrative error were removed or consoli-
dated into one record. Cleaning and consistency checking of the 
final dataset will be undertaken by examining the distribution of 
variables, the range of individual variables, and missing data.
Ethics and information governance
To undertake this work, we require access to patient identifiable 
data without individual consent. We will apply to the Secretary 
of State for Health through the Confidentiality Advisory Group 
(CAG) to obtain approval for this work. After data linkage (see 
earlier section) we will destroy all identifying data and under-
take all analyses using the pseudonymised dataset outlined in 
Figure 2. We will also seek ethical approval for the study 
from an NHS Research Ethics Committee. We believe that the 
benefits of this study for the migrant population outweigh any 
risks. The primary risk that could be anticipated is a data breach 
of sensitive information; we are developing a comprehensive 
data management and data sharing plan to minimise this such 
that no risks are anticipated. The dataset will be created and 
analysed by a team with extensive experience of handling 
large datasets securely, and the organisations involved in this 
work (UCL and PHE) have extensive Information Security and 
Governance procedures in place to minimise this risk.
Comparator groups
We will compare three groups in our analyses: 1) non-EU 
international migrants, 2) refugees, and 3) general population 
in England. We aim to disaggregate the non-EU migrants and 
refugees by: 1) age at migration, 2) sex, 3) ethnicity, 4) visa 
category, 5) country of origin, and 6) date of screening. We will 
examine each group over the follow up time period. For refugees, 
we will also examine country of departure as it is often different 
from the country of origin. Due to their smaller numbers, we will 
likely examine refugees by World Health Organisation (WHO) 
region of origin instead of country they migrated from. Final 
geographical categorisations used for migrant groups will be 
taken to minimise risk of disclosure and therefore migrants may 
be grouped into WHO sub-regions. Secondly, we will compare 
the non-EU migrants and refugees to the general population in 
England by deprivation level (Index of Multiple Deprivation 
- IMD - quintile). This will be done using an anonymous HES 
sample. Here the general population will be composed of mostly 
England-born residents, along with other types of interna-
tional migrants who did not partake in one of the two screen-
ing programmes. These include EU migrants, international 
migrants that are not required to get a pre-entry tuberculous 
screening (e.g. migrants from low-tuberculous countries such 
as the United States), irregular migrants (e.g. undocumented), 
and migrants and refugees who arrived before the start of their 
subsequent screening programmes.
Outcomes
We present a series of outcomes for our healthcare and mortality 
analyses. We chose outcomes to ensure our analysis is consistent 
with those used in previous published analyses4,7,8, in addi-
tion to outcomes that are of high interest to researchers but 
that previous studies were not powered to collect. Moreover, 
we have chosen a range of outcomes that collectively reflect 
the priorities of health policy makers as well as migrants and 
refugees who attended our patient engagement workshops on 
consent process, data linkage and analysis.
Hospital-based healthcare outcomes. We will profile the 
following hospital-based healthcare outcomes in non-EU 
migrants and refugees: 1) hospital attendances (inpatient, outpa-
tient, and A&E), 2) hospital admissions (inpatient), 3) duration 
of hospital admission, and 4) 30 day emergency readmis-
sions. We will explore these four outcomes by sub-conditions 
where appropriate. The clinical definitions and methodological 
approaches for each outcome are provided in Table 1. Full 
clinical definitions of each outcome’s subgroup are provided in 
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Table 2. HES currently uses ICD-10, the 10th version of the 
international classification of diseases and related health 
problems, to code for conditions and OPCS-4, the classification 
of interventions and procedures, to code all interventions and 
procedures. ICD-10 and OPCS-4 code lists for each are provided 
in Extended data file 2–5.
Mortality outcomes. We will examine the following mortality 
outcomes in non-EU migrants and refugees: 1) death and 
2) death due to a specific condition. The clinical definition and 
the methodological approaches for each outcome are provided 
in Table 1. Full clinical definitions of each outcome’s condition 
are provided in Table 2. ONS datasets use ICD-10 codes to code 
for the health condition registered at death. ICD-10 code lists 
for each are provided in Extended data file 2–Extended data 
file 5. Lastly, we aim to examine if the mortality advantage found 
in the literature can be replicated with this migrant and refugee 
population in England.
Entry and exit from cohort
We will include all visa applicants (non-EU migrants) from 101 
countries (see Extended data file 1) with pre-entry tuberculosis 
screening in this study and all refugees who underwent pre-entry 
health assessment.
Individuals will enter the cohort at whichever is the latest of: 
date at which they were screened for tuberculosis pre-entry 
screening or refugee pre-entry health assessment. Individu-
als will be followed up until the earliest of: end of the follow-up 
period (31st December 2018), emigration, or death. Individuals 
found to have tuberculosis at pre-entry screening will not enter 
the cohort as they are not given a certificate of clearance for 
tuberculosis and therefore their visa process is put on hold 
until they are treated and a certificate is then produced. Only then 
will they enter the cohort.
Individuals in our cohort will be at risk of hospital admis-
sion or death from the date of entry until the first of the fol-
lowing events: death, emigration, or the end of the follow-up 
period. Since data were unavailable to indicate whether an 
individual migrant is living in Scotland/Wales/Northern Ireland 
(or resettlement to these countries in the case of refugees), or 
emigration, these events will be accounted for probabilistically 
by multiple imputation and building on previously described 
methods14,22. 
Table 1. Clinical definition and methodological approach for hospital-based healthcare and mortality outcomes.
Outcome Clinical Definition Statistical Definition Example Statistical 
Modelling Approach*
Hospital-based healthcare outcomes
Hospital attendances Number of hospital 
attendances in inpatient, 
outpatient, or A&E.
Binary indicator for attendance with specific condition 
(yes/no). Time to event defined as entry into cohort 
date until end of follow up.
Cox proportional hazards 
model
Hospital admissions Admission into the hospital as 
an inpatient.
Binary indicator for specific admission (yes/no). Time 
to event defined as entry into cohort index attendance 
until the end of follow up.
Cox proportional hazards 
model
Duration of hospital 
admission
Number of days spent in 
hospital as an inpatient.
Numerical indicator for number of days. Cox proportional hazards 
model
30 day emergency 
readmissions
Emergency admissions to any 
hospital in England occurring 
within 30 days of the last, 
previous discharge from 
hospital after admission.
Binary indicator for emergency readmission (yes/no) 
recorded within 30 days of the index admission 
discharge date. Emergency admissions are defined 
as those where the admission method is waiting list, 
booked or planned (11, 12 or 13). To be explored in 
subgroup of people with an initial hospitalisation.
Logistic regression
Mortality outcomes
Death from all 
causes
Deaths in England from any 
cause.
Binary indicator for death due to a all-causes (yes/no). 
Deaths will primarily be identified through linkage to 
ONS deaths registration data, but also through HES 
(where the Method of Discharge field is coded as 
“dead” (4)) as the latter method may better ascertain 
information on recent deaths where there is a delay in 
death registration (e.g. because a coroner’s report is 
required).
Calculation of SMR using 
ONS death data by age 
and gender; rates, life 
expectancy
Death due to a 
specific condition
Death due to one of the 
subgroup conditions.
Binary indicator for death due to a specific condition 
(yes/no). Time to event defined as entry into cohort 
index attendance until death.
Cox proportional hazards 
model; calculation of SMR 
using ONS death data by 
age and gender; rates, life 
expectancy
*final statistical modelling approach to be confirmed during analysis stage after review of data and modelling assumptions.
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Table 2. Clinical definition for hospital-based healthcare and mortality subgroup outcomes. Extended data can be found at DOI 
10.17605/OSF.IO/FUTS415.
Outcome Subgroups Clinical Definition
Ambulatory care sensitive (ACS) 
conditions (Extended data file 4)
Conditions where effective community care can prevent inpatient hospital admission or death.
Amenable conditions Conditions where hospital admissions or death could be avoided through high quality preventative 
healthcare16.
Preventable conditions Conditions where all or most hospital admissions or deaths from a specific cause could be avoided 
by established medical or public health interventions16.
Avoidable conditions (Extended 
data file 2 and Extended data 
file 3)
Conditions that are considered preventable, amendable or both, where each admission or death 
is only counted once. When cause of admissions or death falls within both the preventable and 
amenable definition, all admissions or deaths from that cause are counted in both categories when 
they are presented separately16.
Sexual and reproductive health 
conditions and treatments 
(Extended data file 5)
Conditions where hospital admissions or death is for a sexual and reproductive health outcome 
or treatment. These are split into seven domains based on the Guttmacher-Lancet commission on 
sexual and reproductive healthcare and rights: abortion, contraception, human immunodeficiency 
virus and other sexually transmitted infections, maternal and neonatal health, fertility, gender-based 
violence and reproductive cancers17.
Tuberculosis, HIV, Hepatitis B 
& C (Extended data file 2 and 
Extended data file 3)
Conditions where hospital admissions or death is for tuberculosis, HIV, Hepatitis B or Hepatitis C.
Common mental and behavioural 
disorders (Extended data file 6)
Conditions where hospital admissions or death is for a common mental and behavioural disorder.
Multimorbidity Co-existence of two or more chronic conditions, each one of which is either: (1) a physical non-
communicable disease of long duration, such as a cardiovascular disease or cancer; (2) a mental 
health condition of long duration, such as a mood disorder or dementia; or (3) an infectious disease 
of long duration, such as HIV or hepatitis C18.
All causes* Death due to any cause.
ICD-10 chapter*19 Death due to a specific conditions, such as infectious disease, disease of the blood, cardiovascular 
diseases, digestive disease, genitourinary disease, musculoskeletal disease, nervous disease, 
respiratory disease, endocrine disease, injury or external causes, mental and behavioural, or 
neoplasms20.
Maternal deaths* Death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the 
duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its 
management but not from accidental or incidental causes21.
*Subgroup only applies to the mortality outcomes.
Sample size
1,700,000 non-EU migrants who underwent pre-entry tuber-
culous screening to enter the UK between 2005-2017 will be 
included. After removal of duplicate records there will be just 
over 1,500,000 unique individuals. Approximately 10% of 
migrants move to Scotland and Northern Ireland and will not 
be linked to HES and ONS data. Therefore, linkage to HES and 
ONS will be on approximately 1,380,000 non-EU migrants.
Table 3 provides examples of the precision by which preva-
lence estimates will be estimated and the changes in relative risk 
detectable between migrant subgroups. The study therefore has 
sufficient statistical power (80%) to detect changes in common 
outcomes (e.g. admission due to ambulatory care sensitive 
condition) and rare outcomes (e.g. mood (affective) disorders), at 
the 5% significance level.
Analysis plan
Our analysis plan has been designed to meet our two main 
objectives of profiling hospital-based healthcare and mortality 
outcomes for non-EU migrants and refugees. To achieve this, 
we will undertake the analysis in three phases. In the first 
phase we will summarise and compare baseline characteristics 
(see Table 4) between the non-EU migrant group, the refugee 
group and the general population in England. With the excep-
tion of ethnicity, all baseline characteristics are anticipated to 
be fully recorded (chronic disease is presumed to be absent 
unless recorded). Missing values for ethnicity will be analysed 
grouped as “not recorded”. In the second phase, we will sum-
marise the hospital-based healthcare and mortality outcomes 
of the three study populations, using the general population of 
England as a reference. We will estimate the crude association 
between each of the outcomes and these study population groups. 
We will then re-estimate the association between each of the 
outcomes and the study population group after adjusting for char-
acteristics at the time of hospital admission or time of death: age, 
sex, chronic disease, calendar time period, and reason for hospi-
tal admission or cause of death. Finally, an appropriate statisti-
cal model (selected on the basis of meeting assumptions such as 
proportional hazards for Cox regression) will be used to analyse 
the relationship between the study comparison groups and each of 
the outcomes. Crude models will be fitted prior to adjustment for 
“baseline” measurements at or before the index admission. We 
will write-up the analysis in accordance with the Reporting of 
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Table 3. Sample size calculations that illustrate the 95%CIs with which the rates for common (ACS admission) and 
uncommon (Mood (affective) outcomes can be estimated for migrant subgroups, and the difference between these 
migrant subgroup rates that can be detected assuming type 1 error = 0.05 and power = 0.8.
Outcome/risk factor
Example Overall rate (95%CIs) per 
1000 person years at risk Subgroup size
95%CIs of 
rate*
Hazard ratio 
reduction detectable**
Admissions due to ambulatory 
care sensitive (ACS) conditions
8.4 (8.4-8.4)23 5000 
(e.g. Cambodian 
migrants)
6.1-11.3 0.64
10000 
(e.g. Kenya)
6.7-10.4 0.73
100000 
(e.g. Bangladesh)
7.8-9.0 1.0*
Mood (affective) disorders 0.42 (0.42-0.43)24 5000 - -
10000 0.0-1.0 0.3
100000 0.38-0.46 1.0*
*This column indicates the confidence interval for the subgroup assuming that the subgroup rate is the same as the general population 
overall rate (e.g. 8.4 per 1,000 for ACS conditions).
**This column indicates the hazard ratio detectable for the subgroup using the largest group as baseline (e.g. 100,000 Bangladesh) and 
assuming this baseline group has the same rate as the overall population level (e.g. 8.4 per 1,000 for ACS conditions).
Table 4. Patient characteristics in the time prior to the index admission will be collated as baseline 
measurements.
Variable Description
Age at migration (in years) as recorded at the non-EU migrant pre-entry tuberculous 
screening or refugee pre-entry health assessment
Sex as recorded at the non-EU migrant pre-entry tuberculous screening or 
refugee pre-entry health assessment
Ethnicity as recorded at the non-EU migrant pre-entry tuberculous screening or 
refugee pre-entry health assessment
Visa category as recorded at the non-EU migrant pre-entry tuberculous screening or 
refugee pre-entry health assessment
Country of origin as recorded at the non-EU migrant pre-entry tuberculous screening or 
refugee pre-entry health assessment
Country of departure as recorded at the refugee pre-entry health assessment
Date of pre-entry tuberculous screening or 
refugee pre-entry health assessment
as recorded at the non-EU migrant pre-entry tuberculous screening or 
refugee pre-entry health assessment
Length of time in England prior to index 
admission/death
(in years) at the given time point will be estimated as (date of 
admission/death - month & year of pre-entry screening/365.25)
Age at index admission/death (in years) at a given time point will be estimated as ((date of admission/
death – month & year of birth)/365.25) for the index admission or death
ICD-10 chronic disease conditions
obtained from all admissions at the index admission (sub-divided into 
categories of: 
   1.   mental health/behavioural 
   2.   cancer/blood disorders 
   3.   chronic infections 
   4.   respiratory 
   5.   metabolic/endocrine/nutritional 
   6.   renal/genitourinary 
   7.   musculoskeletal/dermatological 
   8.   neurological, 
   9.   cardiovascular
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studies Conducted using Observational Routinely-collected Data 
(RECORD) statement25.
Sensitivity analyses
To determine the robustness of our final results and to quantita-
tively account for any uncertainty, sensitivity analyses will be 
conducted to examine the extent to which our findings are 
affected by changes in methods or values of unmeasured vari-
ables. We are uncertain about the length of time non-EU migrants 
remain in England following their arrival. In a first sensitivity 
analysis, all migrants will be assumed to stay for one and a half 
years, the median time of stay for an international migrant, pro-
viding a lower estimate of person time at risk. In a second 
sensitivity analysis, all migrants will be assumed to stay until the 
end of the study period of 31st December 2017. This is the more 
conservative assumption, and whilst it unrealistically inflates 
the denominator, it provides a lower bound for the estimates of 
incidence and prevalence.
Dissemination of results
At the end of the study we will convene a group of policy 
makers, non-governmental organizations, migrants and refugees 
and the public to feedback the results of our study and seek 
suggestions on ways to take this work forwards. We will also 
disseminate our findings to relevant policy makers and schemes 
through a series of regional workshops.
Study status
We are currently in the process of seeking ethical and 
Confidentiality Advisory Group (CAG) approvals for the study.
Discussion
We describe a novel record linkage study that will use routine 
data from multiple sources to generate the Million Migrant study. 
The study has several advantages including the opportunity to 
accurately identify migrants in UK routine health records and 
their subsequent health needs. The strengths of this approach 
are the creation of a highly-powered cohort study that harnesses 
existing data to uncover health patterns in this often difficult to 
identify or invisible population. The Million Migrant study aims 
to improve evidence on hospital-based events and mortality and 
will better position the scientific community to inform policy 
makers and civil society with rigorous data about the health of 
migrants in England.
There are several limitations to our study. We will be unable 
to include data from primary care due to the lack of a national 
dataset available for this purpose. As a result, we will be 
unable to examine any contribution to the health and care of the 
individuals from primary and community or social care. 
Designing a new linkage of the million migrant cohort to pri-
mary care data would provide a more comprehensive understand-
ing of primary care usage within this population and allow us to 
identify new opportunities for community-level interventions, and 
this may become a possibility in the coming years. We also do 
not include data from all migrant sub-groups. Irregular migrants 
(e.g. entrants who enter, stay or work in a country without the 
necessary authorization such as undocumented entrants, failed 
asylum seekers, visa overstayers, children born to irregular migrant 
couples), migrants entering on a temporary visa (e.g. tourist 
visa), EU and EEA migrants, international migrants from low- 
incidence tuberculosis countries who subsequently do not have a 
pre-entry tuberculous screening (e.g. United States of America, 
Chile, and Egypt), and international migrants who emigrated 
before the start of either health screening programme will not be 
captured. As such, the study findings will not be generalisable 
to these groups. Additionally, although smaller in number, these 
groups could potentially be included in our randomly gener-
ated sample from the general population residing in England. 
This is important to consider in our interpretation of the find-
ings. Our proposed study will not be able to assess whether the 
healthcare and mortality outcomes were affected by frequency of 
travel abroad, health service usage abroad, uncertainty in length of 
residence in the UK, movement in the UK outside of England to 
access healthcare, or wider socio-environmental determinants of 
health. These factors will be later examined through the creation 
of an electronic longitudinal cohort study using a mobile phone 
application to collect data on the health of migrants after moving 
to the UK (part of RWA’s Wellcome Trust Fellowship, Public 
health data science to investigate and improve migrant health in 
the UK). 
To help ensure impact from the work, we have engaged with 
policy makers, non-governmental organizations, migrants and 
refugees and the public throughout the design and conduct of 
the study to ensure relevance to them and prepare a pathway for 
impact, and will continue to do this through to the end of the 
project. In designing this study, we held a workshop with 
international migrants and refugees to understand their views 
on the consent process, data linkage and analysis. We have also 
involved national and international policy makers in the design 
stage.
In England today, nearly 15.6% of the population are international 
migrants, constituting an important and large group of people. 
However, there is still a limited understanding of their health 
needs and use of secondary care in the NHS. This study will fill an 
important gap in the literature and provide local, regional and 
national policy makers with detailed information about the 
health needs of this population. Our results will include informa-
tion about how and where healthcare services can be improved 
to prevent hospital admissions, and data on the causes of death 
in this large and important group of people. Whilst maintaining 
the highest scientific and ethical standards on the use of exist-
ing data, or big data, we will set forth an avenue to advance 
knowledge and good practices in the field of migration and 
health, for the UK and internationally.
Data availability
Underlying data
No data is associated with this article.
Extended data
All extended data is publicly available on Open Science Frame-
work: Million Migrants study of healthcare and mortality 
outcomes in non-EU migrants and refugees to England: Analysis 
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protocol for a linked population-based cohort study of 1.5 million 
migrants, https://doi.org/10.17605/OSF.IO/FUTS415 
Files available:
•    Extended data 1: Tuberculosis pre-entry screening rollout 
phases
•    Extended data 2: Revised definition of avoidable conditions
•    Extended data 3: Avoidable conditions definition for chil-
dren and young people
•    Extended data 4: Definition of Ambulatory Care Sensitive 
Conditions
•    Extended data 5: Definition of sexual and reproductive 
health outcomes
•    Extended data 6: Definition of mental and behavioural 
disorders
•    Extended data 7: Deduplication of records
•    Extended data 8: RECORD checklist
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
Reporting guidelines
To review the study’s RECORD checklist, please see Extended 
data file 8.
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This article summarises the analysis protocol for a linked population cohort study.  The aim of the study is
to describe hospital-based healthcare and mortality outcomes among 1.5 million non-EU migrants.  This
is because immigration status is not routinely collected on a large scale in the UK to allow comparative
studies of health outcomes between migrant populations and UK-born populations.  
The research team plan to compare outcomes between migrants, refugees and the general population of
England.  To do this they will collate three sources of data: 1. Data from pre-entry screening of non-EU
migrants from high burden TB countries 2. Pre-departure health screening of refugees. 3 National hospital
episode statistics. 4. ONS death records.
The authors clearly identify a gap in knowledge with respect to migrant health and therefore this large
study could provide extremely novel and valuable insights.
Protocol:
To justify the focus on non-EU migrants the authors state, "We focus on non-EU migrants because of their
availability in this dataset, but also because EU migrants are more likely to dual-use health systems and
less likely to need adaptation in terms of cultural competence " 
- I have reviewed the paper referenced.  It is a systematic review which compiled predominantly
qualitative studies thus I could not find evidence to support the claim that "EU migrants are more likely" to
dual-use health systems.  Equally, I think the claim that EU migrants are less likely to need adaptation in
terms of cultural competance essentialises the experience of being an EU migrant.  Equally, not all
aspects of an individuals culture play an equal role in determining how they access care.  I suggest that
the authors simply make the statement that the focus on non-EU migrants is because of the availability of
the data set.  Similarly, I think that it should be made very clear that it is not simply a focus on non-EU
migrants but non-EU migrants from a very specific cohort of 101 countries, the majority of which are
LMIC. Given pre-entry screening for TB is performed in high burden countries and TB burden at country
level has been shown to be related to GDP which in turn is related to mortality, does this not introduce a
selection bias at the beginning? I realise this is mentioned in the limitations section of the discussion but I
think it would be useful to comment on the different characteristics of the groups not included and how
these might affect the study outcomes.
I also think it should be made clear that not all refugees are screened pre-departure, some individuals
claim asylum on arrival in the UK prior to becoming refugees.  Please could the authors make a comment
on the representativeness of this cohort of refugees in relation to the wider refugee population in the UK?
13
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 on the representativeness of this cohort of refugees in relation to the wider refugee population in the UK?
Ethics
I note in figure 2 (if I have interpreted it correctly) a plan to share identifiable data between Public Health
England and NHS Digital.  I wondered whether the authors have sought assurances that such data will
not be shared with other parts of government for the purposes of immigration control as has previously
occurred through NHS Digital.  Beyond this concern the authors have clearly outlined a robust plan of
psuedoanonymisation.  
Comparator groups
The authors state the general population of England will be "composed of mostly England-born
residents".  Is country of birth routinely collected to allow this assumption or will the size/ methods of
selecting this matched sample ensure they represent the background England population which the
authors point out later in the paper consists of 15% of individuals originally born outside the UK?
Analysis plan
The authors state in the introduction "the study includes analyses that acknowledge the wider
determinants influencing the health of international migrants such as the legal, social, economic and
health structures and systems, health service access and support, exposures and behaviours, and
epidemiological changes associated with population mobility" but no details of how this will be done are
provided. Then in the discussion the authors state they will be unable to assess the impact of the "wider
socio-environmental determinants of health" - please could they therefore clarify the earlier point as I think
it is a little mis-leading as it stands.
I cannot comment on the details of the mathematical aspects of the analysis plan as this is outside the
range of my expertise.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
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